Company Filing History:
2 out of 46 
1 out of 28 
1 out of 36 Years Active: 2013-2020
Title: The Innovative Mind of Franz Xaver Heinz
Introduction
Franz Xaver Heinz is a notable inventor based in Vienna, Austria, with a significant impact in the field of medical biotechnology. Holding a total of four patents, Heinz has dedicated his career to innovating methods for disease detection and vaccine development, particularly concerning flaviviruses.
Latest Patents
One of his latest inventions is a method for the detection of an IgM antibody specific for flavivirus in a sample. This advanced method involves several crucial steps including the use of a solid support with immobilized IgM-binding molecules and the detection of specific IgM antibodies through a complex binding process. Additionally, he has developed an attenuated live vaccine for flavivirus which includes a specific mutation in the capsid protein. This innovative approach aims to enhance the vaccine's efficacy by maintaining the integrity of the hydrophobic region within the protein structure.
Career Highlights
Throughout his career, Heinz has been associated with prominent companies in the biotechnology sector, specifically Valneva Austria GmbH and Intercell AG. His work within these organizations has contributed significantly to advancements in vaccine technology and antibody detection methods, showcasing his skills as a forward-thinking inventor.
Collaborations
In his journey, Franz Xaver Heinz has collaborated with esteemed colleagues, including Christian Mandl and Petra Schlick. These partnerships have furthered his research efforts and expanded the impact of his inventions in the scientific community.
Conclusion
Franz Xaver Heinz stands out as a key figure in the development of innovative solutions for public health challenges, with his patents reflecting a commitment to improving disease detection and vaccine efficacy. His contributions will continue to influence the fields of virology and immunology, paving the way for future advancements.